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Abstract
Helminth parasites remain a major constraint upon human health and well-being in many
parts of the world. Treatment of these infections relies upon a very small number of thera-
peutics, most of which were originally developed for use in animal health. A lack of high
throughput screening systems, together with limitations of available animal models, has
restricted the development of novel chemotherapeutics. This is particularly so for filarial
nematodes, which are long-lived parasites with a complex cycle of development. In this
paper, we describe attempts to visualise the immune response elicited by filarial parasites in
infected mice using a non-invasive bioluminescence imaging reagent, luminol, our aim
being to determine whether such a model could be developed to discriminate between live
and dead worms for in vivo compound screening. We show that while imaging can detect
the immune response elicited by early stages of infection with L3, it was unable to detect the
presence of adult worms or, indeed, later stages of infection with L3, despite the presence of
worms within the lymphatic system of infected animals. In the future, more specific reagents
that detect secreted products of adult worms may be required for developing screens based
upon live imaging of infected animals.
Introduction
Drug discovery against parasitic organisms has undergone something of a renaissance in
recent years with the impact of the London Declaration (https://www.gov.uk/government)
and the involvement of funding agencies such as the Bill and Melinda Gates Foundation and
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Drugs for Neglected Diseases initiative (DNDi). The World Health Organisation (WHO) aim
of eradicating several parasitic infections, such as the lymphatic filariae (http://www.filariasis.
org), together with the increasing threat of drug resistance [1,2] underpins the requirement for
novel chemotherapeutics. For efficient drug discovery a high throughput screen (HTS) of large
chemical libraries is a desirable first step for the detection of chemotypes with activity against
the organism in question.”Hits” then undergo chemical modification to increase their drug-
like properties whilst maintaining their selective anti-parasite activity. For protozoan parasites
such as Plasmodium, Leishmania or Trypanosoma species, various HTS have been devised that
facilitate the identification of novel agents [3,4]. For helminth parasites, there are few compara-
ble methods that allow screening of large chemical libraries (thousands of compounds) to
identify those with anthelmintic activity. In part this relates to differences in the basic biology
of helminth and protozoan parasites; many protozoans can be cultured in vitro and will repli-
cate under such conditions providing a relatively simple readout of drug activity. In contrast,
helminth parasites are notoriously difficult to culture [5] and do not replicate in vitro.
For parasites such as filarial worms, there is a pressing need for drugs with activity against
adult worms to help achieve the goal of elimination. Most primary screens for anti-filarial
compounds rely upon motility assays, which can be scaled up to test a few hundred com-
pounds at best. Recent studies have resulted in significant improvements by the use of video
recording and computational algorithms that provide an objective measure of drug efficacy
[6,7]. Once compounds are identified from such in vitro screens, they are commonly tested in
various animal models prior to further development. For filarial worms, the paucity of small
rodent systems for subsequent in vivo testing of potential hits further impedes drug discovery.
For parasitic protozoa, the ability to transfect parasites with plasmid constructs expressing
fluorescent or bioluminescent reporter proteins, such as mCherry or luciferase, has provided a
useful tool for the in vivo visualization of parasites. Using this technology it is possible to track
parasites within the live animal and to demonstrate the efficacy of various drugs or immunolog-
ical interventions over time in the same cohort of animals (see [8,9], for example). Applying
transgenic technology to parasitic helminths is significantly more difficult, although there have
been notable successes with Schistosoma [10] and Strongyloides species [11]. However, genetic
modification of filarial nematodes pose particular problems, as the developmental cycle is long
(a minimum of 3 months) and complex, involving an arthropod vector, and there are no free-
living stages that could be used to amplify the numbers of transfected worms [12]. In this study,
we investigated an alternative approach to visualizing filarial worms in live animals by applying
non-invasive bioluminescence imaging of the host response to infection. In inflammatory con-
ditions, probes such as luminol and lucigenin have proved to be useful tools for distinguishing
the differential role of immune cells in various pathologies [13]. For example, luminol is acti-
vated by the myeloperoxidase activity of neutrophils [14], while lucigenin requires NADPH
activity, characteristic of macrophages [13]. A similar concept was applied to image the eosino-
philic response elicited by Schistosoma mansoni infection in the tissues, only in this case the
mice expressed an inducible luciferase reporter gene driven by an eosinophil-specific promoter
[15]. Here, we demonstrate that while whole mouse in vivo imaging using luminol as a substrate
can detect the early stages of infection with the third stage larvae (L3) of Brugia pahangi, the
current limitations of the system are such that its usefulness in drug screening is restricted.
Materials and Methods
Ethics statement
All animal protocols were carried out in accordance with the guidelines of the UK Home Office,
under the Animal (Scientific Procedures) Act 1986, following approval by the University of
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Glasgow Ethical Review Panel. Experiments were performed under the authority of the UK
Home Office, project number 60/4448. Animals were anaesthetized for surgery using a mixture
of Ketamine and Dormitor and for imaging using an isoflurane anaesthesia unit. At the end of
the experiments animals were sacrificed by cervical dislocation or CO2 inhalation.
Parasites and infection of mice
The Brugia pahangi life cycle was maintained by serial passage through mosquitoes (Aedes
aegypti, Refm) and jirds, Meriones unguiculatus, as described previously [16]. All mouse exper-
iments were performed with male BALB/c mice, 6–8 weeks of age, and animals were main-
tained in filter top cages for the duration of the experiments. A transplant model was used to
study the response elicited by B. pahangi adult worms, exactly as described previously [17,18].
In brief, adult female worms were removed from the peritoneal cavity of infected jirds, rinsed
in HBSS and 10 worms transplanted into the peritoneal cavity of each of four anaesthetized
BALB/c mice. Four sham control animals that underwent the same procedure, but had no
adult worms implanted were included for imaging. To distinguish between worm and sur-
gery-related responses six control animals that were injected intraperitoneally with HBSS 12
days before imaging but underwent no surgery were included for analysis. Imaging (described
in “IVIS reagent and imaging”) was performed on d17 and d27 post-transplantation.
For larvae infections mice were injected with L3 of B. pahangi harvested from mosquitoes
infected 9 days previously. L3 were washed in sterile Hanks Balanced Salt Solution (HBSS,
Invitrogen) and counted into groups of 50. For the intraperitoneal (ip) infection, L3 were
taken up into approximately 250 μl of sterile HBSS in a standard syringe and injected into 12
mice while six control animals received an equivalent volume of HBSS. Six infected and six
control mice were imaged on day 7, 12 and 18 p.i. (as described below) while the remaining six
infected mice were sacrificed at day 6 p.i. to assess larvae and host cells in the peritoneal cavity.
For intra-dermal (footpad) injection, L3 were taken up into a maximum volume of 50 μl in a
single use Myjector U-100 insulin syringe (Terumo Medical Corporation, MD, USA) and
injected into the right-hand side (RHS) footpad of seven mice. The left-hand side (LHS) foot-
pad received an equivalent volume of HBSS. Syringes were flushed with HBSS following injec-
tion and the remaining L3 counted, as 100% of the worms are rarely injected. Mice were
imaged on day 4 and 11 p.i. as described below. In a further experiment, groups of three mice
were injected via the footpad with 5, 25 or 50 L3 and imaged on day 5 and 11 p.i.
IVIS reagents and imaging
Luminol sodium salt (Sigma-Aldrich) was prepared in PBS at 50 mg/ml and frozen until
required for imaging. At the indicated time points, luminol was injected subcutaneously (sc)
into the neck at 200 mg/kg body weight. Mice were imaged 20 min later under isoflurane
anaesthesia using an IVIS Spectrum imaging system (Caliper Life Sciences).
Images were acquired in bioluminescence mode with an open emission filter, for 1 min
exposures, large binning, and 1 f/stop, and captured with a charge-coupled device (CCD) cam-
era. Analysis was performed using Living Image software (Caliper Life Sciences). The absolute
unit of photon emission was given as radiance (photons/second/cm2/steradian). Regions of
interest (ROIs) were manually selected over the abdomen or foot, depending on the site of
infection, to quantify photon emission as total flux in photons per second (photons/sec).
Histological evaluation
On day 7, 14 and 21 post-injection of L3 into the footpad, mice (four per time point) were
euthanised and the limbs processed for histological examination following fixation in 10%
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neutral buffered formal saline. Tissues were decalcified in 4% EDTA/formalin and then pro-
cessed to paraffin blocks. Sections approximately 2.5 μm thick were cut and stained with hae-
matoxylin and eosin following standard procedures. The involvement of eosinophils in the
inflammatory response in infected limbs was investigated by staining sections using modified
haematoxylin and eosin and Congo Red staining protocols, as described [19].
Cytokine measurements by bead array
At days 7 and 14 post-infection (p.i.), mice (five infected and five naive per time point) were
euthanised and the popliteal lymph nodes (popLN) were removed and processed for in vitro
culture essentially as described previously [20]. In brief, LN were disrupted by passage through
a 0.22 μm cell strainer and 1x106 cells/ml were cultured in RPMI-1640 containing L-glutamine,
sodium bicarbonate (Sigma) and 10% heat-inactivated fetal bovine serum for 48 h at 37˚C in
an atmosphere of 5% CO2 in air. Cells were cultured in the presence or absence of Brugia
antigen at a concentration of 10 μg/ml. Antigen was prepared from adult worms exactly as
described previously [20]. Supernatants were collected after 48 h of culture and processed for
cytokine analysis using a Bio-Plex Pro mouse cytokine assay kit (Bio-Rad).
Statistical analysis
All p values were determined with Prism software (GraphPad Software Inc) using the test
described in the figure legends.
Results
IVIS following intra-peritoneal infections
As the greatest need for novel anti-filarial compounds is for drugs with macrofilaricidal activ-
ity, we initially assessed the utility of an in vivo imaging system (IVIS) for detecting live adult
worms following transplantation. In this experiment, four BALB/mice were infected by ip
transplantation with 10 adult female B. pahangi. Sham control animals were treated identically
(undergoing a sham operation) except that they received no worms, and surgery control ani-
mals were injected ip with HBSS but underwent no surgery. Mice were allowed to recover fully
from the operation and then imaged using luminol on day 17 following infection. Luminol
was injected subcutaneously into the neck to minimize potential inflammatory responses in
the abdominal region due to tissue damage caused by substrate injection. Although the lumi-
nescent signal obtained was restricted to the abdominal cavity, the overall signal was relatively
low (mean 6.7 x 105 ± 2.1 x 105 photons per second in infected mice compared to 2.3 x 105 ±
1.4 x 105 photons per second in six HBSS-injected mice, p< 0.05), and there was no difference
in intensity from infected and sham control animals (mean 5.6 x 105 ± 1.7 x 105) (Fig 1). The
increase in bioluminescence in the sham-operated compared to HBSS-injected mice (although
not significant) suggests that the surgery was sufficient to elicit a response detectable by IVIS.
This increase in signal may mask small changes in inflammation elicited by the presence of
worms. Imaging was also carried out at day 27 p.i., but no discrimination was obtained
between sham-operated and infected animals.
As the problem with adult infections was most likely a result of a response to the invasive
procedure required to implant the worms, we next infected 12 BALB/c mice by ip inocula-
tion with 50 L3, while a further six animals received HBSS alone. At 7, 12 and 18 days p.i.,
six control and six infected animals were imaged following subcutaneous (sc) injection of
luminol. A significant increase in luminol-specific signal was observed for B. pahangi-
infected mice at day 7 (mean 5.012 x 105 ± 3.8 x 105 after luminol injection compared to
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9.7 x 104 ± 9.2 x 104 without luminol injection). However no specificity in the luminescent
signal was detected at any time point, as mice receiving an injection of HBSS alone gave sim-
ilar signals (S1 Fig). To ensure that the infection was successful, the remaining six animals
in this experiment were sacrificed at day 6 p.i. and the numbers of developing larvae were
assessed by lavage of the peritoneal cavity with HBSS. Worm recoveries were variable
0–79% (mean 35±27%) in keeping with previous data from this model system [18], but five
out of six animals contained developing worms. In addition, the peritoneal washings from
infected animals showed evidence of a pronounced cellular infiltrate, consistent with the
presence of worms.
Fig 1. In vivo imaging of MPO-specific bioluminescence in mice implanted with adult B. pahangi.
BALB/c mice were infected intraperitoneally by transplantation with 10 female adult B. pahangi (B.p). Sham-
operated mice (Sham) received no worms and control mice (Ctl) received an intraperitoneal injection of HBSS
but underwent no surgery. On day 17 post-infection mice were imaged using an IVIS spectrum 20 minutes
after subcutaneous injection of 200 mg/kg luminol. Representative images of 2 mice per group are shown.
The colour scale indicates bioluminescence radiance in photons/second/cm2/steradian. Graphs show the
bioluminescence total flux (in photons/second) within the same abdominal region of interest. Each symbol
shows the total flux for a single mouse, lines indicate the means (n = 4–6 mice) and error bars show SD
(*p < 0.05 using a one-way ANOVA with Dunn’s post-test).
doi:10.1371/journal.pone.0168602.g001
Imaging of Brugia pahangi Infection
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IVIS following footpad inoculation with L3
As the results obtained with ip infections were not sufficiently discriminating, mice were then
infected intradermally via the footpad, a route that leads to localisation of the worms in the
lymphatic system [21]. In these experiments, mice received L3 into the RHS footpad with the
LHS injected with HBSS as control. Imaging was carried out at various time points after injec-
tion of luminol sc into the nape of the neck. During the initial stages of infection (days 4–7), a
specific luminescent signal was observed from the infected limb following injection of luminol.
In the representative experiment shown in Fig 2 all seven mice showed stronger signal in the
infected limb. Quantifying the signal showed a significant difference between infected and
uninfected limbs (p = 0.0026, see Fig 2A). However, in all animals by day 11 p.i., the signal was
reduced in the infected limb and there was no significant difference in myeloperoxidase-spe-
cific bioluminescence between uninfected and infected limbs at this time point (see Fig 2B).
This lack of specificity at later time points was due to a reduction in signal from the infected
limb but also a slight increase in signal and variability from the uninfected limb. This experi-
ment was repeated with equivalent results.
In the next experiment, mice were injected with different numbers of L3 (5, 25 or 50 in the
syringe) to investigate whether there was a correlation between the original inoculum and the
intensity of the luminescent signal. As observed previously, at an early time point p.i. (day 5 in
this experiment) the signal from each infected limb was much stronger than from the unin-
fected limb (p< 0.05 for 5 and 25 L3 and p<0.001 for 50 L3 compared to uninfected control
limbs, see Fig 3A). However, the difference between infected and uninfected limbs was mini-
mal by day 11 p.i. (see Fig 3B). Although the higher worm dose (50 L3) resulted in an elevated
signal in all three mice, compared to the more variable signal observed between mice infected
with lower numbers of worms, no significant correlation between the intensity of the signal at
day 5 p.i. and the number of worms inoculated was observed.
Histological observations
In order to ascertain whether the slight increase in luminescence at later time points in the
uninfected limbs could be explained by migration of the L3 from the site of injection, histopa-
thology was carried out on infected and uninfected limbs to confirm the presence of parasites
and inflammation only in the infected limb. In the first experiment, a single time point was
analysed at 21 days p.i. Here the difference was immediately visible between infected and unin-
fected limbs. The lymphatic vessels in the infected limbs were dilated, appeared to contain floc-
culent material and were often surrounded by inflammatory cells. In contrast, the uninfected
limb showed no such changes (Fig 4A). Parasites were observed within the lumen of some lym-
phatic vessels, although whether these larvae were viable remains uncertain. In a subsequent
experiment, histology was carried out over a time course of 7, 14 and 21 days p.i. with similar
results (see Fig 4). At day 7, some animals showed minimal to mild interstitial inflammation in
the subcutis or fascial planes. Nematode parasites were visible within the lumen of lymphatic
vessels in the subcutis or fascial planes in some sections but there was no indication that para-
sites were present in uninfected limbs (Fig 4B). At 14 and 21 days p.i. there was an increased
prominence of inflammatory changes in the fascial planes, and to a variable extent in the sub-
cutis and deep dermis. In addition, in some animals a distinct pattern of perilymphangitis and
lymphangitis was observed (Fig 4C and 4D). In some instances inflammatory cells were noted
to cause complete disruption of the lymphatic vessel structure with obliteration of the lumen
caused by accumulation of inflammatory cells and necrotic debris associated with remnants of
degenerate parasites (Fig 4D). Inflammatory infiltrates in the subcutis and fascial planes, as
well as those associated with lymphatic vessels, comprised variable proportions of eosinophils,
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Fig 2. In vivo imaging of MPO-specific bioluminescence in mice infected with B. pahangi L3 larvae.
BALB/c mice were injected with 50 L3 of B. pahangi into the RHS footpad (B.p) and with HBSS into the LHS
footpad. On day 4 (A) and day 11 (B) post-infection mice were imaged using an IVIS spectrum 20 minutes
after subcutaneous injection of 200 mg/kg luminol. Representative images of 3 mice per group are shown.
The colour scale indicates bioluminescence radiance in photons/second/cm2/steradian. Graphs show the
bioluminescence total flux (in photons/second) within the same footpad region of interest (ROI, red ovals in
images). Each symbol shows the total flux for a single mouse, lines indicate the means (n = 7 mice) and error
bars show SD (**p < 0.01 using a Mann-Whitney test).
doi:10.1371/journal.pone.0168602.g002
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Fig 3. MPO-specific bioluminescence after infection with different doses of B. pahangi. BALB/c mice
were injected with 5, 25 or 50 L3 of B. pahangi into the RHS footpad (B.p) and with HBSS into the LHS footpad
(Ctl). On day 5 (A) and day 11 (B) post-infection mice were imaged using an IVIS spectrum 20 minutes after
subcutaneous injection of 200 mg/kg luminol. Graphs show the bioluminescence total flux (in photons/
second) within the footpad region of interest. Each symbol shows the total flux for a single mouse, lines
indicate the means (n = 3 mice per L3 dose) and error bars show SD (*p < 0.05, ***p < 0.001 using two-way
ANOVA with Bonferroni post-test).
doi:10.1371/journal.pone.0168602.g003
Imaging of Brugia pahangi Infection
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Fig 4. Histopathology of B. pahangi infected and uninfected limbs in a mouse model. BALB/c mice were injected with
50 L3 of B. pahangi into the RHS footpad and with HBSS into the LHS footpad and analysed on the days p.i. as indicated. (A)
uninfected mouse, Day 21, HBSS-injected limb: there is no inflammation in the fascial plane (B) infected mouse, Day 7: a
filarial nematode is present within the lumen of a dilated lymphatic vessel in the fascial plane. (C) infected mouse, Day 14
prominent lymphangiectasis and lymphangitis in the fascial plane. (D) infected mouse, Day 21: marked inflammatory infiltration
obliterating the lumen of a lymphatic vessel. Inset: remnants of degenerate nematodes within the lumen surrounded by
inflammatory cells. (E) infected mouse (same animal as section C), Day 14: the inflammatory infiltrate affecting the lymphatic
vessel in the fascial plane is characterised by the presence of many eosinophils highlighted by the modified haematoxylin
eosin method. (F) infected mouse, Day 21: nematodes surrounded by intense inflammatory infiltration comprising large
numbers of eosinophils highlighted by the modified Congo Red protocol.
doi:10.1371/journal.pone.0168602.g004
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neutrophils, lymphocytes and macrophages. Staining with the modified haematoxylin and
eosin and Congo Red methods confirmed that eosinophils were the predominant cell type
within the inflammatory infiltrate affecting the lymphatic vessels and surrounding remnants
of parasites (Fig 4E and 4F).
Cytokine analysis
To further explore the immunological events associated with infection, the cytokine profile in
antigen-stimulated popLN cells from both infected (RHS) and uninfected (LHS) limbs, as well
as from naive mice, was assessed using bead array technology. As can be seen from Fig 5, the
results were variable, with individual infected animals producing elevated levels of all cytokines
at each time point assayed. However, some general points can be made: Th2-associated cyto-
kine levels were higher overall, as might be expected given the nature of the infection; IL-3, IL-
4, IL-5, IL-10 and IL-13, were all elevated in popLN cells from infected limbs, particularly so
when re-stimulated with Brugia antigen. Individual mice that had high levels of one cytokine
generally had higher levels of all other cytokines, suggesting these animals were particularly
responsive. With the exception of IL-5, there was little difference in the median levels of Th2
cytokines between days 7 and 14 (see Fig 5); IL-5 levels increased between day 7 and day 14 in
infected mice. While IL-2 levels were increased in responsive mice, most Th1-associated cyto-
kines were either not detected, or were at very low levels (IL-12p70 and IFN-γ). Chemokines
such as MCP-1 (CCL2), MIP-1α (CCL3) and MIP-1β (CCL4) tended to be higher in infected
compared to uninfected limbs, and in addition MIP-1β was higher in popLN cells from the
uninfected limb compared to naive mice.
Discussion
Helminth parasites remain a major burden on human health in tropical regions of the world
[22]. There are no vaccines available and control still relies upon the use of drugs, many of
which were developed decades ago. In addition, the treatment of many helminth infections
relies upon a single compound, giving rise to concerns about the possible development of
anthelmintic resistance [23]. Several programmes are underway in an attempt to identify novel
compounds suitable for human use, but the methodologies available for screening and testing
large numbers of compounds, particularly in vivo, remain relatively limited. The aim of the
work undertaken in this study was to determine if the significant progress made in imaging
methods in live animals could be applied to assess the viability of filarial worms in a mouse
model of infection. Specifically, we sought to determine whether the immune response elicited
by living filarial worms could be visualised in vivo using reagents that emit bioluminescence
when exposed to molecules released by immune cells. The best results were obtained by intra-
dermal infection with L3, following which the parasites localise to the draining lymphatic ves-
sels. However the luminescent signal was obvious only during the initial stages of infection as,
by day 11–12 p.i., when the worms have developed to the L4 stage, there was no discrimination
between infected and uninfected limbs.
The lack of specificity at later time points of infection could arise either because of the
migration of developing larvae away from the site of infection or, alternatively, it could reflect
the suppression of immune responses, a well-documented characteristic of lymphatic filarial
nematodes [24,25,26]. Studies in the only fully permissive rodent host of Brugia species, the
Mongolian jird, demonstrated that L3 rapidly migrated from the site of injection in the hind
limb to the lymphatic system, with the majority of developing adults establishing in the lym-
phatics of the spermatic cord [27,28]. In the present study, we observed sections through filar-
ial worms in the local lymphatic vessels of the infected limb at the latest time point examined
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(21 days p.i.) but never in uninfected limbs. To investigate whether a significant number of lar-
vae had migrated from the infected limb, dissection of the whole animal would be necessary.
In addition, the migratory capacity of the L3 may differ between a fully susceptible host (the
jird) and a partially susceptible host (the BALB/c mouse). Varying the numbers of L3 injected
did not result in a longer lasting inflammatory response as detectable by imaging. This
Fig 5. Cytokine production by lymph node cells after in vitro restimulation. BALB/c mice were injected with 50 L3 of B. pahangi into the RHS footpad
and with HBSS into the LHS footpad. Popliteal LN cells were collected from infected limbs of individual mice at d7 (BpD7) and d14 (BpD14) post-infection
and pooled from uninfected limbs (Ctl,● d7,▼d14 p.i.) or naive mice (N). Cells were re-stimulated with media (-) or 10 μg/ml Brugia antigen (+) as
indicated for 48 h at 37˚C, and the cytokine and chemokine production determined by Luminex assay. Values for individual mice are shown in samples
from infected limbs and lines represent median values. The dotted line in each graph shows the limit of detection.
doi:10.1371/journal.pone.0168602.g005
Imaging of Brugia pahangi Infection
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observation accords with previous experiments that demonstrated that cytokine and prolifer-
ative responses were similar in mice given 5, 25 or 50 L3 of B. pahangi by the subcutaneous
route [29].
The BALB/c mouse is semi-permissive for B. pahangi in as much as infection with L3 gives
rise to only a few adult worms and these do not produce microfilariae. However L3 and devel-
oping L4 can be recovered in reasonable numbers at early time points of infection [30], as can
transplanted adult worms [18]. This model was selected for imaging over the more permissive
jird for several reasons: 1) the availability of established protocols for imaging, efficacy and
pharmacokinetic studies in mice, 2) the smaller size of mice compared to jirds increases the
imaging capacity and reduces the compound requirement for dosing, 3) use of inbred mice
compared to outbred jirds reduces variability, thus allowing smaller group sizes, and 4) the
availability of antibodies to mouse proteins and genetically engineered mouse strains expands
the downstream applications of the model.
Infection via the footpad is known to elicit an early burst of IL-4 mRNA and significant
levels of Th2 cytokines by day 7 of infection [20]. However, the ability of filarial worms to
modulate host immune responses is well documented; the absence of a detectable inflamma-
tory response using IVIS reagents at day 10–11 could reflect a progressive down-regulation
of a pro-inflammatory response driven by the parasite. Cells from the draining lymph node
secreted a range of cytokines, with higher levels of Th2 cytokines classically associated with
filarial infection [24]. In addition, specific chemokines were detectable including MCP-1
(CCL2), MIP-1α (CCL3) and MIP-1β (CCL4). Chemokines may also reflect in vivo exposure
to the Wolbachia endosymbiont of filarial worms [31]. However, chemokine levels were sim-
ilar upon in vitro re-stimulation in the presence or absence of filarial antigen. Chemokines
are critical signalling molecules that regulate leukocyte recruitment and trafficking in the
context of inflammatory responses. While some cytokines/chemokines measured in this
study peaked at day 7, histological evaluation of infected limbs demonstrated a time-depen-
dent increase in the inflammatory response from day 7 to day 21 p.i. At 14 and 21 days p.i.
inflammation was characterised by patterns consistent with lymphangitis and perilymphan-
gitis, with infiltrates consisting of eosinophils, macrophages and lymphocytes, and lower
numbers of neutrophils. In some instances the inflammatory infiltrates causing obliteration
of the lymphatic vessels in the subcutis and fascial planes were clearly associated with rem-
nants of degenerate nematode parasites. Consistent with the elevated levels of IL-5 secreted
from popLN cells, eosinophils were particularly abundant in inflammatory foci; in addition,
both MIP-1α and MIP-1β, which remained relatively stable over 2 weeks of infection, are
known chemotactic factors for mouse eosinophils [32]. Previous studies have implicated
eosinophils in killing both microfilariae [33] and later larval stages of filarial parasites [34].
In an elegant study in cattle naturally infected with the filarial worm Onchocerca ochengi, it
was proposed that neutrophils, elicited by the Wolbachia endosymbiont, ‘protect’ the worm
from lethal attack by eosinophils [35]. However, in our semi-permissive mouse model the
most likely scenario is that infection with L3 induces a burst of cytokine/chemokine gene
expression [20], which elicits trafficking of immune cells to the site of infection. While attri-
tion of some of the nematodes follows, those left alive may then down-regulate immune
responses. Such a scenario would correlate with the reduction in signal from IVIS imaging at
later time points, and the relatively stable levels of some cytokines, despite the presence of a
cellular infiltrate. As the L3 of filarial worms have known migratory capacity it was impor-
tant to rule out whether the slight increase in background signal in mice infected with L3
might be explained by migration of the larvae into the uninfected limb. However, we could
detect no evidence of L3 either by histology or by analysis of cytokine levels from the unin-
fected limb.
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Imaging of the immune response limits this in vivo screening model to assessment of poten-
tial chemotherapeutic agents and highlights the desirability of developing imaging agents that
could detect the worms themselves. If such reagents were available they could also be applied
to vaccine studies or to efficacy studies involving immunomodulatory drugs. Filarial worms
secrete a myriad of molecules under in vitro culture conditions, including enzyme activities
such as triose phosphate isomerase, leucyl aminopeptidase and glutathione peroxidase [36,37].
More specific reagents are continually being developed to detect various disease states; for
example, several reagents are already available that detect enzymatic activities of specific prote-
ases, which are useful markers of pathologies such as arthritis, airway inflammation and tumor
progression [38,39,40]. It may be possible in the future to utilise more specific reagents to
detect secretory products of adult worms in vivo.
Supporting Information
S1 Fig. In vivo imaging of MPO-specific bioluminescence in mice injected ip with B.
pahangi L3 larvae. BALB/c mice were injected ip with 50 L3 of B. pahangi (B.p) or with HBSS
(Ctl). On day 7 (A and B), day 12 (C) and day 18 (D) post-infection mice were imaged using
an IVIS spectrum without (A) or 20 minutes after (B, C, D) subcutaneous injection of 200 mg/
kg luminol. Two to three representative mice from each group are shown. The colour scale
indicates bioluminescence radiance in photons/second/cm2/steradian. (E) Graph shows the
bioluminescence total flux (in photons/second) over the abdominal region of interest. Each
symbol shows the total flux for a single mouse, lines indicate the means (n = 3–6 mice) and
error bars show SD (p< 0.05 using a Mann-Whitney test to compare background and MPO-
specific bioluminescence at d7).
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